Program Planners – Editor and Associate Editors and Guest Editors
Mark H. Rapaport, M.D., Editor of FOCUS, and Chairman and Chief of Psychiatric Services, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Ga. No financial relationships with commercial interests.
Dorothy Stubbe, M.D., Editor Communications Commentary, Associate Professor and Program Director, Yale University School of Medicine Child Study Center, New Haven, CT.- No financial relationships with commercial interests.
Laura Dunn, M.D., Co-Editor Ethics Column; Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA; Dr. Dunn reports: Consultant: Otsuka America Pharmaceutical Inc.
Ian A. Cook, M.D., D.F.A.P.A. Editor and Author Patient Management: is Chief Translational Innovation Officer for the Semel Institute for Neuroscience and Human Behavior, and is a Professor with the Department of Psychiatry and Biobehavioral Sciences of the David Geffen School of Medicine, and the Department of Bioengineering of the Henry Samueli School of Engineering and Applied Science at the University of California, Los Angeles. He is also with the Veterans Affairs Greater Los Angeles Healthcare System.
Complementary and Integrative Treatments – Patient Management exercise: Dr. Cook reports that his active biomedical device patents are assigned to the University of California. In the last year, he has advised Arctica Health, Cerêve, and NeuroDetect, and UCLA has received research grant funding from NeoSync, Inc., for his work. He has been granted stock options in NeuroSigma, the licensee of some of his inventions, and he currently is on-leave as its chief medical officer and senior vice president.
David Mischoulon, M.D., Ph.D. Guest Editor and Author: Popular Herbal and Natural Remedies Used in Psychiatry. Dr. Mischoulon reports receiving research/grant funding from the National Center for Complementary and Integrative Health (NCCIH), the National Institute for Mental Health (NIMH), and research support from Nordic Naturals. He has provided unpaid consulting for Pharmavite, LLC, and Gnosis USA, Inc.
FOCUS Author Affiliation and Disclosure Information
Applications of Yoga in Psychiatry: What We Know. Maren Nyer, Ph.D., Maya Nauphal, B.A., Regina Roberg, B.A., Chris Streeter, M.D. The authors report no financial relationships with commercial interests.
Female Sexual Dysfunction: Natural and Complementary Treatments. Christina M. Dording, M.D., and Lisa Sangermano, B.S. The authors report no financial relationships with commercial interests.
Massage Therapy for Psychiatric Disorders. Mark Hyman Rapaport, M.D., Pamela J. Schettler, Ph.D., Erika R. Larson, M.S., L.M.T., Dedric Carroll, L.M.T., Margaret Sharenko, L.M.T., C.P.T., James Nettles, Ph.D., L.M.T., Becky Kinkead, Ph.D. Dr. Schettler reports: Statistical Analysis Consultant to LivaNova; Dr. Nettles reports Novartis Employees Retirement Fund; Consultant Wolf Greenfield - Boston Drug Discovery IP - Expert Witness. All other authors report no disclosures.
Mindfulness-Based Interventions in Psychiatry. Benjamin G. Shapero, Ph.D., Jonathan Greenberg, Ph.D., Paola Pedrelli, Ph.D., Marasha de Jong, M.D.,Gaelle Desbordes, Ph.D. The authors report no financial relationships with commercial interests.
Qigong and Tai-Chi for Mood Regulation. Albert Yeung, M.D., Sc.D., Jessie S. M. Chan, Ph.D, M.P.H., Joey C. Cheung, B.S., Liye Zou, Ph.D. The authors report no financial relationships with commercial interests.
Ethical Challenges in Complementary and Alternative Medicine. Dr. Lavretsky reports grant and research support from the Forest Research Institute/Allergan grant; Alzheimer’s Research and Prevention Foundation; National Center for Complementary and Integrative Health; National Institute of Mental Health; and Patient-Centered Outcomes Research Institute. Dr. Krause reports no financial relationships with commercial interests. Dr. Dunn reports: Consultant: Otsuka America Pharmaceutical Inc.
Complementary and Integrative Therapies in Psychiatry. Taya Varteresian, D.O., M.S., and Helen Lavretsky, M.D., M.S. Dr. Lavretsky reports as above. Dr. Varteresian reports no financial relationships withcommercial interests.
Applied Armamentarium: An Open-Label Study of Doxazosin Extended-Release for PTSD: Findings and Recommendations for Future: Research on Doxazosin: Anne Richards, M.D., M.P.H., Sabra Inslicht, Ph.D., Leslie Micaela Ruoff, B.S., Thomas James Metzler, M.A.,Lizabeth Alexandra Goldstein, Ph.D., Christen Mary Chapman, M.S.W., Samantha Qirko Hubachek, B.A. no disclosures. Thomas Coogan Neylan, M.D: research medications from Actelion and GlaxoSmithKline for studies funded by the Department of Defense, the Department of Veterans Affairs, and NIMH.
Early Combination Therapy for Type 2 Diabetes Mellitus and Common Comorbid Mental Disorders. Rahn Kennedy Bailey, M.D., Daphne Kaye Sharpe, D.N.P., Marianna Ringel, M.D., Abeer Zeeshan, M.D., M.B.B.S. The authors report no financial relationships with commercial interests.
Keeping Up with Changing Times in Education: Fostering Lifelong Learning of Millennial Learners. Ann C. Schwartz, M.D., William M. McDonald, M.D., Arshya B. Vahabzadeh, M.D., Robert O. Cotes, M.D. William M. McDonald, M.D., reports: research support from the National Institute of Mental Health, National Institute of Neurological Disease and Stroke, Stanley Foundation, Soterix, Neuronetics and Cervel Neurotherapeutics. Arshya B. Vahabzadeh, M.D.: has an employment relationship with Brain Power (Neurotechnology Company); research support from Brain Power (Neurotechnology Company) Triax LLC (Neurotechnology Company); cofounder of a healthcare technology investment company. Robert O. Cotes, M.D. reports: advisory board for Alkermes Pharmaceuticals; speaker's bureau for Otsuka Pharmaceuticals; research funding from Otsuka Pharmaceuticals. Ann C. Schwartz reports no disclosures.
American Psychiatric Association staff involved in planning report no financial relationships with commercial interests:
Tristan Gorrindo M.D., Director, Division of Education, American Psychiatric Association
Kristen Moeller, Director of CME, Associate Director of FOCUS, American Psychiatric Association
FOCUS Editorial Board disclosure is published on the editorial board page of each issue.